Method and apparatus for monitoring glucose levels in a biological tissue

• US 7,254,429 B2
• Filed: 08/11/2004
• Issued: 08/07/2007
• Est. Priority Date: 08/11/2004
• Status: Active Grant

• Current Assignee: Masimo Corporation
• Original Assignee: GlucoLight Corporation
• Inventors: Schurman, Matthew J., Shakespeare, Walter J.
• Primary Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US10/916,236
• Publication Number:
  US 20060063988A1
• Time in Patent Office: 1,091 Days
• Field of Search: 600/316, 600/310, 600/322
• US Class Current: 600/316
• CPC Class Codes: A61B 5/0064 Body surface scanning
• CPC Class Codes: A61B 5/0066 Optical coherence imaging
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/441 Skin evaluation, e.g. for skin disorder diagnosis

Abstract

In accordance with the invention, a low coherence interferometer is used to non-invasively monitor the concentration of glucose in blood by shining a light over a surface area of human or animal tissue, continuously scanning the light over a two dimensional area of the surface, collecting the reflected light from within the tissue and constructively interfering this reflected light with light reflected along a reference path to scan the tissue in depth. Since the reflection spectrum is sensitive to glucose concentration at particular wavelengths, measurement and analysis of the reflected light provides a measure of the level of glucose in the blood. The measurement of glucose is taken from multiple depths within blood-profused tissue, and sensitivity is preferably enhanced by the use of multiple wavelengths. Noise or speckle associated with this technique is minimized by continuously scanning the illuminated tissue in area and depth.

Claims

1. A method of monitoring the blood glucose concentration within a biological tissue comprising the steps of:

providing light having scattering properties sensitive to the glucose concentration within the tissue;

continuously scanning the light over a two-dimensional area of the tissue and, at the same time, interferometrically scanning the tissue in depth, the two-dimensional area being substantially perpendicular to a depth direction; and

detecting interferometrically scanned light to obtain measurements of light reflected from at least one depth and analyzing the measurements to determine a glucose concentration within the tissue.

2. The method of claim 1 wherein light from one or more sources is split into a sample beam and reference beam,

the continuous scanning comprises scanning of the sample beam;

and

the interferometric scanning in depth comprises varying the phase of the reference beam and interfering it with scanned light reflected from the tissue.

3. The method of claim 1 wherein the light is low coherence light.

4. The method of claim 1 wherein the light comprises at least two different wavelengths having measurably different scattering properties for glucose-containing tissue or indicators of such tissue.

5. The method of claim 1 wherein the light comprises infrared or near infrared light.

6. A method of measuring blood glucose concentration within a human or animal subject comprising the steps of:

splitting light into a sample beam and a reference beam;

illuminating and scanning a two-dimensional area of the tissue of the subject with the sample beam;

collecting the sample light reflected from within the illuminated subject tissue;

interfering the reflected light with the reference beam; and

measuring the interfered light and processing the measurements to determine the concentration of glucose in the blood of the subject tissue, wherein the processed measurements comprise non-imaged tissue measurements.

7. The method of claim 6 wherein the light is provided by one or more low coherence sources.

8. The method of claim 6 wherein the reference light is adjusted to constructively interfere with the light reflected from a selected depth within the subject tissue.

9. The method of claim 6 wherein scanning a two-dimensional area comprises continuously scanning the tissue of the subject to reduce speckle.

10. The method of claim 9 further comprising the step of scanning multiple depths within the subject in order to reduce speckle.

11. The method of claim 6 wherein the concentration of glucose is calculated from light reflected from blood-perfused tissue.

12. The method of claim 6 wherein the light comprises at least two wavelengths each having different absorption or different scattering properties for glucose-containing tissues.

13. The method of claim 12 wherein the at least two wavelengths comprise wavelengths at about 1310 nm, and either about 1450 nm or about 820-960 nm.

14. The method of claim 6 further comprising the step of measuring the changes in the hydration level of the tissue.

15. The method of claim 14 further comprising the step of compensating for changes in the hydration level where the level of glucose remains the same.

16. The method of claim 6 wherein at least one of the two wavelengths of light is infrared or near infrared light.

17. An apparatus for measuring the blood glucose concentration of a human or animal subject comprising:

one or more sources of light to provide light at two or more wavelengths;

a sample arm defining a first light path to direct a beam of sample light from the source or sources onto the subject tissue;

a reference arm defining a second light path to direct a beam of reference light from the source or sources to a phase shifter;

a scanner to scan the sample light over a two-dimensional area of the subject tissue, the area being substantially perpendicular to a depth direction;

an interferometer to interfere reflected sample light from the subject tissue with the reference light, the phase of the reference light path adjusted to constructively interfere with reflected sample light from multiple depths;

one or more photodetectors to measure the interfered light; and

a processor to calculate glucose concentration from the measurements.

18. The apparatus of claim 17 wherein the sources of light are low coherence sources and the interferometer comprises a low coherence interferometer.

19. The apparatus of claim 17 wherein the interferometer further comprises:

a beam splitter to split the light from the source into a sample beam and a reference beam; and

a phase shifter to direct the reference beam into interference with reflected light from the subject tissue.

20. The apparatus of claim 19 wherein the beam splitter is a 2×

2 optical splitter.

21. The apparatus of claim 19 wherein the phase shifter is an adjustable reflector.

22. The apparatus of claim 21 wherein the reflector is adjustable to scan multiple depths within the subject tissue.

23. The apparatus of claim 17 wherein the photodetector comprises a photodiode.

24. The apparatus of claim 17 wherein at least one light source comprises a light emitting diode (LED).

25. The apparatus of claim 17 wherein at least one light source comprises a superluminescent diode (SLED).

26. The apparatus of claim 17 wherein the scanner is a movable lenslet array which can be translated or rotated rapidly to reduce speckle.

27. The apparatus of claim 17 wherein the scanner is a movable diffractive optical element which can be translated or rotated rapidly to reduce speckle.

28. A method of measuring blood glucose concentration within a biological sample including blood, the method comprising the following steps:

providing a low coherence interferometer comprising a sample optical beam, a reference optical beam, a reference path phase shifter and one or more photodetectors;

providing a light source for providing a sample beam for illuminating the sample and a reference beam;

scanning the illuminated sample over a two dimensional area with the sample beam, the two dimensional area being substantially perpendicular to a depth direction of the tissue;

interfering the sample light reflected from the sample with the reference beam to select light reflected within the sample; and

collecting the interfered light at a plurality of depths, and analyzing measurements of the interfered light from at least one depth to calculate a measurement of the concentration of glucose in the blood.

29. The method of claim 28 wherein the region of tissue chosen to sample is blood-perfused tissue.

30. The method of claim 28 further comprising the step of continuously adjusting the phase of the reference beam in order to scan multiple depths within the tissue.

31. The method of claim 28 wherein scanning comprises continuously scanning the illuminated tissue to enhance the accuracy of the measurement.

32. The method of claim 31 wherein the sample beam and the reference beam comprises light of multiple wavelengths.

33. The method of claim 32 wherein the wavelengths are about 1310 nm and in the range from about 820 to 960 nm.

34. The method of claim 32 wherein the wavelengths are about 1310 nm and about 1450 nm.